Institute of Oncology Research (IOR)
@institute_of_oncology_research_ior
Bellinzona, Canton Ticinohttp://www.ior.usi.ch Research ServicesOverview
About Institute of Oncology Research (IOR)
The Institute of Oncology Research (IOR), located in Bellinzona (Switzerland) and directed by Prof. Andrea Alimonti, is affiliated to the Università della Svizzera italiana (USI) and hosts researchers from all over the world performing basic and translational research in oncology with special focus on:
cancer biology
genomics
molecular oncology
experimental therapeutics.
The IOR is located in a brand-new high-tech research building that hosts more than 20 different research groups, with state-of-the-art labs and facilities. Together with the Institute for Research in Biomedicine (IRB), the IOR is member of the Bellinzona Institutes of Science (Bios⁺), a recently established non-profit association aiming to promote, support and coordinate scientific research and teaching activities of its members.
At the IOR we believe that science is constantly evolving to improve our understanding of human cancer.
The efforts of our researchers and the resources of the institute are directed towards this challenge, with a commitment to discovering practical and far-reaching solutions to a disease that still impacts on the everyday life of many people around the world.
cancer biology
genomics
molecular oncology
experimental therapeutics.
The IOR is located in a brand-new high-tech research building that hosts more than 20 different research groups, with state-of-the-art labs and facilities. Together with the Institute for Research in Biomedicine (IRB), the IOR is member of the Bellinzona Institutes of Science (Bios⁺), a recently established non-profit association aiming to promote, support and coordinate scientific research and teaching activities of its members.
At the IOR we believe that science is constantly evolving to improve our understanding of human cancer.
The efforts of our researchers and the resources of the institute are directed towards this challenge, with a commitment to discovering practical and far-reaching solutions to a disease that still impacts on the everyday life of many people around the world.